Ovarian cancer and endometrial cancer are both diseases that exhibit high level of chemoresistance that is linked to overactivation of Akt, in some cases directly influenced by PTEN (phosphatase and tensin homolog) loss, in response to chemotherapeutic insults [4, 6, 9, 15]. Here, AKT1 is linked to endometrial cancer.